Pulmonary-Allergy Drugs Advisory Committee; Cancellation

---
identifier: "/us/fr/02-32157"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Pulmonary-Allergy Drugs Advisory Committee; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "02-32157"
section_name: "Pulmonary-Allergy Drugs Advisory Committee; Cancellation"
positive_law: false
currency: "2002-12-19"
last_updated: "2002-12-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-32157"
document_type: "notice"
publication_date: "2002-12-19"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "67 FR 77798"
fr_volume: 67
fr_action: "Notice."
---


#  Pulmonary-Allergy Drugs Advisory Committee; Cancellation

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is canceling the meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for December 20, 2002. This meeting was announced in the *Federal Register* of November 13, 2002 (67 FR 68878).

**FOR FURTHER INFORMATION CONTACT:**

Kimberly L. Topper, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX 301-827-6776, or e-mail: [email protected], or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12545.

Dated: December 16, 2002.

Linda Arey Skladany,

Associate Commissioner for External Relations.